INTRODUCTION
Methyl CpG binding protein 2 (MeCP2) was initially identified as a nuclear protein that binds to cytosine-methylated DNA within dinucleotide CpG elements (1, 2) . In early studies, MeCP2 was described as a transcriptional silencer because it appeared to maintain the dinucleotide methylation state of target genes and to recruit the corepressor Sin3A and histone deacetylase 1 (HDAC1) and HDAC2 to these methylated CpG sites (3, 4) . However, biochemical and genomics data suggest that, rather than acting strictly as a silencer, MeCP2 acts as a multifunctional regulator of gene transcription (5, 6) , and that it is actively involved in RNA splicing (7) , chromatin remodeling (8, 9) , and transcriptional activation (10, 11) . MeCP2 is especially relevant in biomedicine because of its role in Rett syndrome (RTT) (12, 13) , a progressive neurodevelopmental disorder that manifests in young girls at a ratio of 1:10,000 (14, 15) . Heterozygous lossof-function mutations in MECP2 underlie the etiology for more than 95% of typical RTT patients (13, 16) ; however, the resultant molecular pathology remains largely elusive (5) . The neurodegenerative phenotype of RTT is the result of the loss of MeCP2 specifically in neuronal cells (17, 18) , and it is unlikely to rely on immune cell dysfunction (19, 20) .
MeCP2 is not limited to the brain, and studies have implicated it in the regulation of immunological disorders. Specifically, polymorphisms in MECP2 in humans have been linked to increased susceptibility to autoimmune diseases, such as systemic lupus erythematosus (21, 22) and primary Sjögren's syndrome (23) . Moreover, MeCP2 associates with CpG elements within the regulatory regions of Foxp3 (24) , which encodes a transcription factor required for the generation of regulatory T (T reg ) cells, although the functional consequence of this association is yet to be examined. Thus, although RTT does not appear to be phenotypically linked to immune cell dysregulation, we postulate that the roles of MeCP2 in neuronal cells and in T cells might nonetheless be mechanistically linked by some common molecular pathways. We therefore generated mice that had a T cell-specific loss of Mecp2 to investigate the potential role of MeCP2 in T cell function and immune regulation. Mechanistically, our investigation identified the microRNA (miR) miR-124, which represses the translation of mRNA for suppressor of cytokine signaling 5 (Socs5), as a direct downstream effector of MeCP2-mediated epigenetic regulation. Functionally, the MeCP2-miR-124-SOCS5 axis was indispensable for the cytokine-dependent activation of signal transducer and activator of transcription 3 (STAT3) in naïve CD4 + T cells and, consequently, for the generation of T helper type 17 (T H 17) cells.
RESULTS

MeCP2 is indispensable for the differentiation of naïve CD4 + T cells into T H 17 cells
Because the association between MECP2 polymorphisms and autoimmune diseases was demonstrated by recent human genetic studies, we used the CD4-Cre transgene to induce specific deletion of Mecp2 in both natural T reg (nT reg ) cells and conventional T (T con ) cells in mice. Because Mecp2 resides on the X chromosome, male transgenic mice carry a single floxed allele. Examination of sorted T cells, B cells, and of the brain and lung tissues of these CD4-Cre + Mecp2 f/y mice confirmed that loss of MeCP2 protein occurred specifically in T cells, but not in other cell types (fig. S1A). Consistent with earlier reports (25, 26) , we observed that compared to their wild-type CD4-Cre +
Mecp2
x/y littermate controls, CD4-Cre 
x/y mice served as controls in our experiments.
In young adult mice and in mice up to 1 year of age, the deletion of MeCP2 in T cells (Fig. 1A and fig. S1A ) did not result in any overt T cell developmental irregularities ( fig. S1 , B and C) or in spontaneous T cell activation ( fig. S2 ). To examine the intrinsic autoinflammatory potential of CD4 -/-recipient mice at a ratio of 25:1 to induce autoimmune colitis, which is an effector T cell-mediated inflammatory disease of the large intestine (27) . Mice that received wildtype T con cells developed severe experimental colitis, which was evidenced by a continuous loss in body weight; however, the transfer of MeCP2-deficient T cells conferred the recipient mice with disease resistance rather than promoting inflammation (Fig. 1B) . Further histopathological analysis of the colons of these mice illustrated a marked difference in the extent of infiltration by inflammatory leukocytes and in the integrity of the mucosal tissue architecture (Fig. 1C) . In this transfer model, the aberrant generation of T H 17 cells against host microbiota is the major cause of intestinal inflammation (28) . Accordingly, in the mesenteric lymph nodes of mice bearing MeCP2-deficient T con cells, the proportion of CD4 + T cells that produced interleukin-17 (IL-17) was significantly reduced compared to that in mice that received wild-type T con cells (Fig. 1D) .
In response to specific immunization conditions, T con cells proliferate to increase cell numbers, undergo contraction to reduce cell numbers, and then differentiate into various T H cell lineages to orchestrate appropriate immune responses related to host defense and tolerance (29) . Defects in any of these steps could account for the reduced size of the autoinflammatory T H 17 cell population observed in mice that received MeCP2-deficient T con cells. fig. S3 ). However, when we cultured these cells under T H 17-polarizing conditions in vitro, MeCP2-deficient T con cells exhibited severe defects in IL-17A production (Fig. 1E) . Consistent with this, the abundances of mRNAs for Il-17a, Il-17f, and rorc, which encodes the master transcription factor for T H 17 cells, RORgT, were markedly reduced in MeCP2-deficient T H 17 cells compared to those in wild-type cells (Fig. 1F ).
MeCP2 is indispensable for the commitment of naïve CD4
+ T cells to the T H 1 lineage
Interferon-g (IFN-g)-producing T H 1 cells represent another critical T H cell subset that mediates the onset and progression of autoimmune diseases (31, 32) . With our TCR transgenic mouse models, we examined whether MeCP2 played any role in the differentiation of naïve CD4 + T cells into T H 1 cells. When naïve CD4 + T cells were cultured under T H 1-polarizing conditions in vitro, the amount of IFN-g produced by the MeCP2-deficicent CD4 + T cells was substantially reduced compared to that produced by wild-type CD4 + T cells ( Fig. 2A) . To validate this phenotype in vivo, we sorted and transferred wild-type or MeCP2-deficient LLO118 T cells into TCRa -/-recipient mice, which lack endogenous ab T cells, and then immunized the recipient mice subcutaneously with LLO 190-205 peptide emulsified in complete Freund's adjuavant (CFA). The effector T cells that were generated in vivo were subsequently rechallenged in vitro with the same antigen to assess their functional differentiation. As observed in vitro ( Fig. 2A) , MeCP2-deficient CD4 + T cells were markedly impaired in their ability to differentiate into IFN-g-producing T H 1 cells (Fig. 2B) . To exclude the possibility that this phenotype was limited to the LLO118 TCR, we directly challenged wild-type or MeCP2-deficient mice with keyhole limpet hemocyanin (KLH) protein through the footpad to induce delayedtype hypersensitivity (DTH), a classical T H 1-dominated immune response. Defects in T H 1 responses were apparent in mice with a T cell-specific deletion of MeCP2, as characterized by limited footpad swelling (Fig.  2C) , reduced infiltration by inflammatory cells (Fig. 2D) , and reduced numbers of T H 1 cells in the draining lymph node (Fig. 2E) ) of histone H3 (H3K4me2), and the trimethylation status of He3K4 and H3K27 (H3K4me3 and H3K27me3) across critical regulatory regions of Il17 and Ifng in MeCP2-deleted T cells. Despite observing some minor differences within some regions, we could not identify unidirectional changes in the accessibility of these cytokine genes ( fig. S4 ). Because the differentiation path of naïve CD4 + T cells is primarily determined by their response to different environmental cytokines, we next considered whether loss of MeCP2 affected cytokine signaling. Cytokines activate various transcription factors within the family of STAT proteins (29) ; in particular, the differentiation of naïve CD4 + T cells into T H 17 cells requires STAT3 activation (34) (35) (36) . In both naïve and antigen-stimulated ("primed") CD4 + T cells, loss of MeCP2 did not alter the abundance or activity of STAT3 protein; however, it did dampen the IL-6-dependent phosphorylation of Tyr 705 of STAT3, the hallmark of STAT3 activation (Fig. 3A) . Similarly, in the context of stimulation of cells with IFN-g, loss of MeCP2 substantially inhibited the activation of STAT1 (Fig. 3B) , a signaling intermediate that is critical for the generation of T H 1 cells. Together, these data suggest that the loss of MeCP2 results in the inhibition of multiple STAT signaling pathways.
In addition to its proinflammatory role during immune responses, STAT3 is also highly abundant in the central and peripheral nervous systems, and the activation of STAT3 is essential for the survival, differentiation, and regeneration of neurons and glia cells (37) . On the basis of our findings in T cells, we investigated whether the STAT3 signaling defect that resulted from a deficiency in MeCP2 was also evident in the nervous system. We knocked down MeCP2 in primary human astrocytes with specific small inhibitory RNA (siRNA) and then stimulated these cells with ciliary neurotrophic factor (CNTF), an important neuroprotective and neuropoietic cytokine that functions through the STAT3 pathway (38) . The loss of MeCP2 attenuated STAT3 activation in human astrocytes (Fig. 3C ). In addition, we crossed mice carrying conditional Mecp2 alleles with mice carrying an estrogen receptor (ER)-Cre transgene, isolated neural stem cells and progenitor cells in neurosphere cultures, and induced the Cre-mediated deletion of Mecp2 by treating the cells with tamoxifen in vitro. Stimulation of the primary neurosphere cultures with CNTF revealed similar deficiencies in the activation of STAT3 in cells expressing astrocyte-specific (GFAP + ) or neuron-specific (MAP2B + ) lineage markers (Fig. 3D) . Together, these data suggest that MeCP2 is required for optimal STAT3 activation in both immune and neuronal cell types. 
SOCS5 protein accumulates in MeCP2-deficient CD4 + T cells
Upon stimulation of cells with the appropriate cytokines, STAT3 signaling is tightly controlled by the activation of Janus kinases (JAKs) and various negative feedback mechanisms, including those mediated by the SOCS family of proteins (39) . Through quantitative polymerase chain reaction (PCR) analysis, we profiled the expression of 70 genes related to STAT signaling in naïve CD4 + T cells that were left untreated or were cultured under T H 1-or T H 17-polarizing conditions. These tests failed to identify any substantial differences between wild-type and MeCP2-deleted T cells at the mRNA level (fig. S5) ; however, at the protein level, we consistently observed a marked increase in the abundance of SOCS5 protein in naïve MeCP2-deficient CD4 + T cells (Fig. 4, A and B ). Upon stimulation with antigen and IL-6, MeCP2-deficient T cells displayed a delay in the production of SOCS5 protein, which reiterated the defect in initial STAT3 signaling ( Fig. 4C and fig. S6 ). Furthermore, in response to prolonged stimulation of cells, the loss of MeCP2 also resulted in an increase in the accumulation of SOCS5 protein ( Fig. 4D and fig. S6 ), which spanned the duration of time required for T H 17 cell generation.
SOCS5 inhibits STAT3 activation and the differentiation of naïve CD4 + T cells into T H 17 cells
Unlike for SOCS1 and SOCS3, studies on the function of SOCS5 in lymphocytes remain limited (40, 41) , and its effect on the generation of T H 17 cells is unknown. However, SOCS5 is a potent inhibitor of STAT3 in M1 macrophages and human embryonic kidney (HEK) 293T cells (42) . and MeCP2 KO mice were left untreated or were activated in vitro with anti-CD3 and anti-CD28 antibodies together with IL-6 (50 ng/ml) for the indicated times. Cells were analyzed by Western blotting with antibodies specific for the indicated proteins. Western blots were subjected to densitometric analysis, and the intensities of the bands corresponding to SOCS5 were normalized to those corresponding to b-actin and were calculated relative to those of WT cells at time zero. The data are representative of three independent experiments. Western blots from other experiments can be seen in fig. S6 . The samples from WT and MeCP2 KO CD4 + T cells that were activated up to 1 hour were analyzed on one gel, whereas those from samples stimulated for longer times were analyzed on a different gel, which is indicated by the vertical lines. Through retroviral transduction, we ectopically expressed SOCS5 in primary LLO118 TCR transgenic T cells to try to mimic the effect of loss of MeCP2. With a relatively modest increase in SOCS5 abundance compared to that in cells transduced with control retrovirus (Fig. 5A) , the responses of SOCS5-expressing T cells to IL-6 were impaired (Fig. 5B) (Fig. 5, C and D) .
To further determine whether this defect was intrinsic or the result of competitive disadvantage, we transferred each of these two T cell populations into separate mice and challenged them with the same immunization protocol. In the setting of ex vivo examination (Fig. 5E ) and in vitro rechallenge with antigen (Fig. 5F ), we identified even more pronounced defects in the T H (Fig. 6A ). In agreement with this finding, epigenetic analysis across the Socs5 locus showed that MeCP2-deficient and wild-type CD4 + T cells did not substantially differ in either histone modification (H3 acetylation and H3K4 dimethylation and trimethylation) ( fig. S8A ) or DNA methylation ( fig. S8B ). Therefore, we speculated that MeCP2 regulated SOCS5 abundance in T cells indirectly at the posttranscriptional level.
MicroRNAs (miRNAs) are one of the principal molecular machineries responsible for posttranscriptional regulation (43) . Although most miRNAmediated repression involves at least moderate destabilization of target mRNAs, 11 to 16% of the regulation is attributed solely to translational inhibition (44) . On the basis of the divergent abundances of SOCS5 mRNA and protein in MeCP2-dificient CD4 + T cells, we speculated that miRNAs might be a key player in the regulation of SOCS5. Through quantitative PCR analysis, we analyzed the expression profiles of~400 miRNAs from wild-type and MeCP2-deficient cells. Because of the role of MeCP2 in neural cells, we narrowed our analysis by focusing on miRNAs that decreased in MeCP2-deficient mouse CD4 + T cells and in MeCP2-deficient primary human astrocytes (Fig. 6B) . We found five miRNAs that were decreased in abundance in both cell types. Among these candidates, miR-124 was computationally predicted to target Socs5 mRNA at a highly conserved site ( fig. S9) .
miR-124 is one of the most abundant miRNAs in the vertebrate central nervous system (45) . Loss of miR-124 causes severe defects in neuronal maturation and survival (46) . In addition, data from a clinical study suggest that the expression of miR-124 is dynamically modulated in human T cells from patients with sepsis, and an increase in miR-124 abundance limits the anti-inflammatory effects of steroids (47) . To quantify the abundance of miR-124 in CD4 + T cells, we generated a standard curve from a synthesized RNA template ( fig. S10A, left panel) and quantitated the copy number of miR-124. With this assay, we estimated miR-124 to be in the range of 4 × 10 7 copies/mg total RNA in naïve CD4 + T cells ( fig. S10A,  right panel) . This is similar to the amount of miR-19b, a miRNA that regulates T cell effector responses (48) . In the absence of MeCP2, the abundance of miR-124 was consistently reduced in naïve CD4 + T cells (Fig. 6C ) and in T cells that were stimulated by antigen and cytokines ( fig. S10B) .
Mature miR-124 is generated from three distinct precursor transcripts that are coded within three highly conserved genomic loci (pri-miR-124-1 on chromosome 14, pri-miR-124-2 on chromosome 3, and pri-miR-124-3 on chromosome 2). As was previously demonstrated in the nervous system (46), the pri-miR-124-1 locus is also the dominant precursor of mature miR-124 in T cells: the abundances of pri-miR-124-2 and pri-miR-124-3 were below the detection limit in our quantitative PCR assays. On the basis of the information collected from the ENCODE project, the proximate regulatory regions for pri-miR-124-1 transcription are located within the -4.7-to +3.5-kb region that surrounds its transcription initiation site. Our ChIP assays showed that in naïve CD4 + T cells, MeCP2 readily associated with multiple CpG islands within the -2.8-to +2.4-kb region (Fig. 6D ). Using H3K4 dimethylation as an epigenetic marker, we also examined the genomic accessibility and transcriptional capacity of these regions. In wild-type CD4 + T cells, the -2.8-and -1.6-kb regions, which were associated with enriched MeCP2 binding, constituted regions with higher accessibility. Indeed, loss of MeCP2 protein reduced the accessibility across this locus (Fig. 6E) . Furthermore, when MeCP2 was lost, the reduced chromatin accessibility resulted in dampened transcription of pri-miR-124-1 in naïve CD4 + T cells (Fig. 6F) , as well as in T cells subjected to inflammatory stimuli ( fig. S10C ). These data suggest a direct role for MeCP2 in promoting the transcription of pri-miR-124-1.
miR-124 inhibits the translation of Socs5 mRNA in CD4 + T cells
To determine whether miR-124 connected a deficiency in MeCP2 with the accumulation of SOCS5, we first used a luciferase-based reporter assay to verify that the predicted targeting site in the 3′ untranslated region (UTR) of Socs5 ( fig. S9 ) was specifically targeted for suppression by miR-124 ( Fig. 7A and fig. S11A ). Furthermore, when miR-124 was ectopically introduced into antigen-primed LLO118 T cells ( fig. S11B ), the abundance of SOCS5 protein was reduced compared to that in the control cells (Fig. 7B) , without there being any substantial effect on Socs5 mRNA abundance (Fig. 7C) , which mirrored the pattern of expression seen in MeCP2-deficient T cells. In primed wild-type T cells stimulated with IL-6, the forced expression of miR-124 markedly delayed the kinetics of dephosphorylation of STAT3 (Fig. 7D and fig. S12A ), reinforcing the idea that the primary target(s) of miR-124 are inhibitors of STAT3 signaling. Finally, we used a retroviral vector to restore miR-124 abundance in MeCP2-deficient T cells similarly to that in wild-type T cells ( fig. S11C ). The restoration of miR-124 partially rescued the activation of STAT3 in MeCP2-deficient T cells (Fig. 7E and fig. S12B ). Phenotypically, the exogenous miR-124 substantially augmented the numbers of both wild-type and MeCP2-deficient LLO118 T cells that differentiated into T H 17 cells. The restoration of miR-124 in MeCP2-deficient T cells fully rescued IL-17 production both at the population level and on a percell basis (Fig. 7, F and G) . In reciprocal loss-of-function studies, we sought to corroborate the idea that miR-124 promoted the differentiation of naïve CD4 + T cells into T H 17 cells. To this end, we treated T H 17-polarized LLO118 T cells with a locked nucleic acid (LNA) oligonucleotide capable of functionally inhibiting miR-124 (anti-miR-124 LNA) (49) . Compared to untransfected cells in the same culture, T H 17-polarized CD4 + T cells transfected with the anti-miR-124 LNA demonstrated reduced IL-17A production (Fig. 7H ), effectively phenocopying the T H 17 cell differentiation defect caused by the loss of MeCP2. Together, these data suggest that miR-124-mediated targeting of SOCS5 might account for the impaired differentiation of MeCP2-deficient T cells into T H 17 cells.
DISCUSSION
Since its identification as the causal factor of RTT, MeCP2 has been extensively studied in the nervous system; however, the molecular mechanism by which MeCP2 drives pathology remains largely elusive. Here, we dissected its function in T cells and determined that MeCP2 is indispensable for the differentiation of T con cells (fig. S13 ). We showed that MeCP2 plays a critical role in promoting multiple cytokine signaling pathways by supporting the expression of miR-124 and restraining negative feedback that targets STAT3. Blocking miR-124 or forcing the expression of its target SOCS5 in wild-type CD4 + T cells partially recapitulated the signaling and differentiation defects associated with MeCP2 deficiency. In addition, we found that a similar mechanism operated during CNTF signaling in primary neuronal and glial cells. STAT3 is a necessary inflammatory signal that stimulates the differentiation of naïve CD4 + T cells into T H 17 cells, as well as being a vital neurotrophic transcription factor for neuronal survival and regeneration. Mutations in the gene encoding STAT3 cause a severe immunodeficiency disease, the Job/Buckley syndrome, one of the symptoms of which is scoliosis (50) . Notably, RTT patients are also prone to the development of scoliosis as a comorbidity (51); coincidentally, mice with osteoblast-and osteocyte-specific loss of Stat3 develop a severe spinal deformity at 3 to 4 weeks of age (52) . If this STAT3 signaling defect could be validated in the nervous systems of RTT patients, then it could provide a potential molecular target for the development of therapies, or guidance for current growth factor-based clinical trials.
Loss-of-function mutations in MECP2 lead to RTT in humans, whereas overexpression of MECP2 leads to MECP2 duplication syndrome (MDS), a neurological disorder with similar symptoms to those of RTT (53) . The neuropathological similarities between RTT and MDS could be overstated because their shared symptoms are common for many other neurodevelopmental disorders. Nevertheless, it is safe to conclude that the abundance of functional MECP2 is critical to the integrity of the central nervous system. In terms of CD4 + T cells, patients with MDS experience recurrent respiratory tract infections (54) , and MeCP2-overexpressing mice are defective in mounting efficient T H 1 cell responses against Leishmania major (55) . Surprisingly, we found that similar to the effect caused by overexpression of MeCP2, loss of MeCP2 in mouse T cells also led to impaired T H 1 cell differentiation and T H 1-mediated responses. With our current knowledge of T cell biology, it is difficult to interpret how the loss and gain of Mecp2 could result in the similar phenotype of inhibiting T H 1 cell differentiation; however, what is intriguing is the mechanistic aspect. We speculate that a critical set of immunoregulatory genes are modulated by MeCP2 in a delicate balance. This balance may depend on the divergent biochemical features of this protein: for a specific regulatory region, MeCP2 can reinforce DNA methylation (repressive remodeling) (56) and elicit histone acetylation (activating remodeling) (10) . Therefore, deletion of MeCP2 could result in both enhanced DNA demethylation and reduced histone acetylation, although the overall effect of loss of MeCP2 in a T H 1-critical region would be predominantly the inhibition of transcription. Overexpression of MeCP2, on the other hand, could potentially counteract local demethylation and result in a mechanistically distinct, but phenotypically similar, suppression of the transcription of T H 1-related genes. Therefore, we speculate that, for certain genes, the overarching role of MeCP2 in transcriptional regulation could be switched from being supportive to being suppressive, depending on its concentration. However, immunodeficiency has not been found among RTT patients. We speculate that this apparent discrepancy results from differential degrees of loss of function of MeCP2. Immune function is intact in most RTT patients who bear heterozygous mutations in MECP2, and we also failed to detect substantial defects in the generation of T H 1 and T H 17 cells in mice with a heterozygous deletion of Mecp2 ( fig. S14 ), whereas we observed that profound immunodeficiency ensued upon homozygous loss of Mecp2.
Because early studies identified MeCP2 as a transcriptional silencer, more recent work has largely focused on the role of MeCP2 in regulating gene expression at the mRNA level (10, 57, 58) . However, this view is somewhat at odds with expression profiling studies on samples from RTT patients, which have shown that only a limited subset of genes are dysregulated at the mRNA level (59, 60) . In experiments with Mecp2-deleted mouse models, expression differences were identified for additional genes, but most changes were very subtle (10, 61) . In T cells, we found that the major defect associated with Mecp2 deletion was in STAT signaling, which was caused by the accumulation of SOCS5 protein; however, none of these changes were detectable at the mRNA level. Especially in wildtype naïve CD4 + T cells, the divergence between the amounts of SOCS5 mRNA and protein is marked: abundant mRNA did not result in even a modest increase in the amount of protein. This indicates that active posttranscriptional suppression of SOCS5 is required for optimal and sustained T cell responses to cytokines. We identified miR-124 as the responsible suppressive factor whose expression is tightly controlled by MeCP2. If a similar miRNA-mediated mechanism operates in the signaling networks of neuronal and glial cells, it would likely do so without marked changes in mRNA expression and might therefore be more difficult to detect with traditional transcriptome analyses.
MATERIALS AND METHODS
Mice
Mice homozygous for the floxed Mecp2 allele were purchased from The Jackson Laboratory (B6.129P2-Mecp2 ) were generated by crossing floxed Mecp2 mice with the cd4-cre or lck-cre mice for more than 10 generations. -/-recipients (300 ml per mouse per injection). Recipient mice were weighed throughout the course of the experiments and were euthanized at the experimental endpoints for immunological and histological analysis. For the DTH reaction, wild-type and MeCP2 KO littermates were subcutaneously immunized with KLH protein (100 mg per mouse) in CFA. Seven days after immunization, mice were rechallenged with KLH (50 mg per mouse) or phosphate-buffered saline (PBS) in each lateral footpad.
Mouse models of IBD and the DTH reaction
Forty-eight hours later, footpad swelling was measured before the mice were euthanized for immunological and histological analyses.
Induction of CD4
+ T cell differentiation and analysis of cytokine production Lymphocytes from the lymph nodes and spleens of LLO118 TCR transgenic mice were primed with 5 mM LLO 190-205 peptide under various T Hskewing conditions for 4 days. Cytokine production by CD4 + T cells was determined by intracellular staining after 4 hours of stimulation with 0.9 nM PMA (phorbol 12-myristate 13-acetate) and ionomycin (0.5 mg/ml, Sigma) in the presence of brefeldin A (5 mg/ml, Sigma) and 2 mM monensin (eBioscience). CD4 + T cells were sorted on a flow cytometer based on cell surface CD4 abundance, and relative mRNA abundances were measured by quantitative PCR analysis. T H cell-skewing conditions were as follows: T H 1-skewing condition: recombinant mouse IL-12 (50 ng/ml, PeproTech), purified anti-IL-4 antibody (10 mg/ml, 11B11), and recombinant mouse IL-2 (50 U/ml, PeproTech); T H 2-skewing condition: recombinant mouse IL-2 (50 U/ml), recombinant mouse IL-4 (50 ng/ml, PeproTech), purified anti-IFN-g antibody (10 mg/ml, XNG1.2), and anti-IL-12 antibody (5 mg/ml, BD Biosciences); T H 17-skewing condition: recombinant mouse IL-6 (20 ng/ml, PeproTech), recombinant transforming growth factor-b (4 ng/ml, PeproTech), purified anti-IFN-g antibody (10 mg/ml, XNG1.2), and purified anti-IL-4 antibody (10 mg/ml, 11B11). Staining antibodies were purchased from BioLegend.
Loss-of-function study with anti-miR-124 LNA 
Quantitative PCR analysis
Total RNA was isolated with the miRVana extraction kit (Ambion) according to the manufacturer's instructions. Reverse transcription was performed with qScript Flex cDNA Kit (Quanta BioSciences). Gene expression was quantified by SYBR Green-based quantitative PCR analysis. The quantitative PCR analysis of mature miRNA was performed as previously described (48) .
Antibodies for Western blotting and intracellular staining
The following primary antibodies were used for detecting proteins by 
ChIP assay and DNA methylation analysis
Genomic DNA was purified with GenElute Mammalian Genomic DNA Miniprep Kit (Sigma, catalog no. G1N79). Methylation analysis was quantified by sequencing of genomic DNA after bisulfite conversion with the MethylDetector kit (Active Motif), PCR amplification, and cloning. ChIP assays were performed with a standard protocol with anti-H3Ac, antiH3K4me2, anti-H3K4me3, and anti-H3K27me3 rabbit polyclonal antibodies (Millipore), anti-MeCP2 (D4F3) XP rabbit monoclonal antibody (Cell Signaling Technology), or a nonspecific rabbit anti-mouse immunoglobulin G (IgG; Jackson ImmunoResearch Laboratories). The amount of DNA immunoprecipitated by antibodies was quantified by quantitative PCR with primers specific for the indicated gene regulatory regions and normalized to the amount of input DNA before immunoprecipitation. For MeCP2 ChIP assays, the ratio of enrichment was determined by normalizing the amount of DNA immunoprecipitated with rabbit anti-MeCP2 antibody to that immunoprecipitated with nonspecific rabbit IgG.
miRNA target predictions, luciferase assays, and T cell transductions miRNA target candidates were predicted by multiple methods assembled on the miRecords Web site (http://mirecords.biolead.org/) (62) . The fulllength 3′UTR of mouse Socs5 was amplified from a 3′ RACE [rapid amplification of complementary DNA (cDNA) ends]-ready cDNA library generated from mouse total T cell RNA. Luciferase activity was determined 72 hours after transfection with a dual luciferase assay kit (Promega). For retroviral transductions, naïve CD4 + T cells from LLO118 TCR transgenic mice were activated with APCs loaded with 10 mM LLO 190-205 peptide for 18 hours and then were subjected to spin infection with retrovirus in 24-well plates at 1258g and 37°C.
Neurosphere cultures and primary human astrocyte cultures
Neurosphere cultures were prepared as described at http://www.nature.com/ protocolexchange/protocols/77. Mice carrying conditional Mecp2 alleles were crossed with mice carrying ER-Cre transgenes to generate Mecp2 f/f ER-Cre + mice. The ventricle tissues of 3-week-old Mecp2 f/f ER-Cre + mice were dissected and dissociated with the papain dissociation system (Worthington Biochemical Corp.) before being plated into 24-well plates for in vitro culture. The cells were first treated with 200 nM 4-hydroxytamoxifen (Sigma) for 3 days to induce Mecp2 deletion in neural stem cells and progenitor cells, and then were cultured in normal medium for an additional 3 weeks, during which time they were passaged every 3 days. Normal human astrocytes (NHA, CC-2565, Clonetics) were cultured in six-well plates with astrocyte growth medium (CC-3186, Clonetics). NHA cells were transfected with siRNA targeting human MECP2 (L-013094-00-0005, Thermo Scientific Dharmacon) or with scrambled, nontargeting siRNA (D-001810-10-05, Thermo Scientific Dharmacon) with Lipofectamine RNAiMAX (13778150, Invitrogen). Seventytwo hours after transfection, cells were cultured in serum-free medium for 2 hours before they were stimulated with cytokines. Whole-cell lysates were then harvested for Western blotting analysis.
Histology
Footpads and colons were excised, inflated with 4% paraformaldehyde in PBS, fixed overnight at room temperature, placed in 70% ethanol, embedded in paraffin, and then stained with H&E.
Statistical analysis
Unpaired and paired two-tailed t tests were used to determine whether the difference between a given set of means was statistically significant. P < 0.05 was considered statistically significant.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/7/316/ra25/DC1 Fig. S1 . CD4 + T cell development is normal in mice with T cell-specific deletion of Mecp2. 
